340B Report

Health Center Challenging 340B Patient Definition Responds to HRSA’s and Drug Companies’ Court Arguments

In Judicial, Providers, RegulatorySeptember 19, 2023415 Views

Genesis Health Care defended its interpretation of the 340B statute in a filing to the U.S. District Court for the District of South Carolina.

There is no evidence to support federal allegations that a South Carolina community health center illegally diverts 340B-purchased drugs to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Uncertain Outlook for GOP Drug Shortages Bill with 340B Provisions

In Legislative, RegulatorySeptember 19, 2023125 Views

William Newton

Rep. Anna Eshoo, ranking member of the E&C Health Subcommittee, was one of multiple Democrats opposed to a Republican drug shortages bill.

The future of a Republican drug shortages bill with 340B provisions remains unclear after it was examined in a contentious [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk Providing 340B Refunds on Blockbuster Drug Ozempic

In Pharma Industry, ProvidersSeptember 19, 2023244 Views

Tom Mirga

Drugmaker Novo Nordisk is issuing 340B refunds for certain purchases of its blockbuster diabetes medication Ozempic.

Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHIP Objects to Hospital Efforts to Target Medicare Advantage 340B ‘Windfall’

In Providers, Regulatory, Trade AssociationSeptember 19, 2023135 Views

Rich Daly

Matthew Eyles, president and CEO of AHIP, objected to hospital-sought rules that target the Medicaid Advantage 340B "windfall."

The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

House Subcommittee Clashes Over 340B Role in Drug Shortages

In Legislative, News AlertSeptember 14, 20231215 Views

William Newton

Legislation sponsored by Rep. Cathy McMorris Rodgers (R-Wash.) was the focus of a partisan clash during a Sept. 14 hearing over changes it would implement for the 340B program.

A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...]